Dynamic Trends and Practice Patterns in Femoropopliteal Revascularization From 2016 Through 2023

J Am Coll Cardiol. 2024 Nov 26:S0735-1097(24)10314-2. doi: 10.1016/j.jacc.2024.10.102. Online ahead of print.

¹ Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
² Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
³ Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: esecemsk@bidmc.harvard.edu.

No abstract available

Keywords: COVID pandemic; femoropopliteal artery revascularization; paclitaxel-coated devices; peripheral arterial disease.